Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. - Wikidata - awgldk - TriplyDB

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

http://www.wikidata.org/entity/Q34760010

about

Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development Inflammation in depression: is adiposity a cause?Is adiposopathy (sick fat) an endocrine disease?New obesity classification criteria as a tool for bariatric surgery indication Modelling age-related metabolic disorders in the mouse At the interface of antioxidant signalling and cellular function: Key polyphenol effects Metabolic complications in liver transplant recipients Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression Potential role of marine algae extract on 3T3-L1 cell proliferation and differentiation: an in vitro approach The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity.Adipocyte turnover: relevance to human adipose tissue morphology.Development of obesity in the Otsuka Long-Evans Tokushima Fatty rat.Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss Bariatric endocrinology: principles of medical practice.Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy.Attenuation of obesity by early-life food restriction in genetically hyperphagic male OLETF rats: peripheral mechanisms.Effect of obesity on mortality and morbidity after coronary artery bypass grafting surgery in Iranian patients.Tools for the identification of bioactives impacting the metabolic syndrome: screening of a botanical extract library using subcutaneous and visceral human adipose-derived stem cell-based assays.Sprouty1 is a critical regulatory switch of mesenchymal stem cell lineage allocation.Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction Dietary stearic acid leads to a reduction of visceral adipose tissue in athymic nude mice.Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats.Long-term obesity levels in female OLETF rats following time-specific post-weaning food restriction.The endocrinology of exercise.Adipose lineage specification of bone marrow-derived myeloid cells.Nonalcoholic fatty liver disease and aging: epidemiology to management.Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.Estrogen signaling in metabolic inflammation Tissue-specific effects of bariatric surgery including mitochondrial function Aging and regional differences in fat cell progenitors - a mini-review.Distinct adipogenic differentiation phenotypes of human umbilical cord mesenchymal cells dependent on adipogenic conditions.Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome Acetylcholine promotes Ca2+ and NO-oscillations in adipocytes implicating Ca2+→NO→cGMP→cADP-ribose→Ca2+ positive feedback loop--modulatory effects of norepinephrine and atrial natriuretic peptide Does nicotinic acid (niacin) lower blood pressure?Metabolic remodeling of human skeletal myocytes by cocultured adipocytes depends on the lipolytic state of the system.Variations in Adipokine Genes AdipoQ, Lep, and LepR are Associated with Risk for Obesity-Related Metabolic Disease: The Modulatory Role of Gene-Nutrient Interactions.RhoGDIβ Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation Differences in the serum nonesterified Fatty Acid profile of young women associated with a recent history of gestational diabetes and overweight/obesity.

P2860

Q22241480-E258546D-228B-4015-A8FA-80C364B2F764 Q24635451-867334A8-F649-47D9-9938-C86DF7F4AF52 Q24655610-64C2379B-316F-456F-8A37-07150818D389 Q26774656-BD2BA83D-4919-46B9-B2F6-347034CC379F Q27024434-69687639-9F92-4DA2-A8FC-9F404EC481DD Q28071627-F7903BA7-139B-4825-92D9-8542A69BB67D Q28073134-3BB44F32-CB15-4598-A77A-DF7E862EA767 Q28076686-8F6B56CF-C17E-43FD-924B-AC2B579088FB Q28831150-5FEDEAA4-EEC9-418D-96C2-41763692EE56 Q33550783-B58AC8C2-7AEF-42BD-A5FE-EA69DFDF2B79 Q33556451-A536A906-1A38-4B4D-8E45-A044B81ADBC9 Q33579179-0CBE33BC-6052-4F86-815C-79E0137A5525 Q33602989-18BC1729-C68A-4A12-BD02-AE6FFE512BD4 Q33677790-09554C91-B447-4613-8249-6C3C2DE470D5 Q33742195-331C4A8A-CF63-48DC-A2C2-03A466085B54 Q33781165-DEC574EF-C29E-4EC5-82F1-5B04CD4B464A Q33807808-D8CA1B2E-B254-4F90-9EE1-8ADB94F705CD Q33890166-CB60B40C-EAE3-4251-A2A1-B069F84285AE Q34072235-50401F5D-F368-4F3B-9E52-0BF1CF4B914F Q34090453-A10FBA12-CAF6-4D37-954F-35358257CFC3 Q34134296-28E4A84A-5208-4408-926F-7ECAFC6D50CE Q34182640-97C42ADD-DEBA-44AA-BA48-7F1C5C057CEB Q34189534-30A21BA5-2ECC-4829-AAFF-48269786E4F2 Q34316560-F242A07F-3A70-4884-AF3A-F91B9D7DF64B Q34332068-087DE77E-FD45-4A86-8F10-1E2D5B63DF2F Q34346254-F0BEBBD9-E29B-4299-AFB3-BB00642FA433 Q34366861-DD42154E-930E-490B-A159-8D679E277303 Q34366918-2B17322D-CA07-46E9-BF57-BBEB5A9BEE63 Q34481216-7D750BF8-C3CC-42F5-9C3E-8CB854D2CB02 Q34512740-8602B8E4-4E29-42C4-B46A-5198FD72F0C1 Q34540615-BCD208AA-1061-470A-BB86-2890E49BFD06 Q34546872-99B574E7-865F-4E41-9027-8AD614D47ECB Q34659424-61A16C0A-FFA9-445D-A3CB-67850B6DC6DE Q34699554-F0C44E04-4485-432E-8EAE-53F03CCDFCED Q34733865-723132FB-1DDB-4E41-AB1E-DEBFE6BF3C32 Q34894236-91FA58B2-7E3F-40AB-8E03-E4008A22A27A Q35063267-AE92A0C2-51F3-4F61-B095-BF845AA0C3B4 Q35104731-37EAE845-5B51-4610-B74B-A7787AB633AF Q35536339-94EF5F09-1624-46A8-9F99-366C4DAD048C Q35642228-03437A0C-3391-4E3E-910E-E5002DFBB9E3

P2860

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

http://www.wikidata.org/entity/Q34760010

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Pathogenic potential of adipos ...... increased visceral adiposity.

@ast

Pathogenic potential of adipos ...... increased visceral adiposity.

@en

Pathogenic potential of adipos ...... increased visceral adiposity.

@nl

type

label

Pathogenic potential of adipos ...... increased visceral adiposity.

@ast

Pathogenic potential of adipos ...... increased visceral adiposity.

@en

Pathogenic potential of adipos ...... increased visceral adiposity.

@nl

prefLabel

Pathogenic potential of adipos ...... increased visceral adiposity.

@ast

Pathogenic potential of adipos ...... increased visceral adiposity.

@en

Pathogenic potential of adipos ...... increased visceral adiposity.

@nl

P1433

Q34760010-9E535BBD-8D47-4CA2-B411-203325A77458

P1476

Q34760010-D56E358A-67A8-41BA-B4AC-061E4B2A261B

P2093

Q34760010-366B0F13-A1F4-4171-83CF-47284C8419EA

Q34760010-439D071F-C5B4-4673-B93C-78B41861C41B

Q34760010-4657B093-ABA9-4C20-8700-2B5200EF432F

Q34760010-53D2DA14-378A-4E16-9C6F-0EB083A9FB42

Q34760010-5B5D850D-ABD5-49F6-86B6-5352BDBD909D

Q34760010-8D79E18B-69D6-4991-BCDA-C462D1CC7899

P304

Q34760010-D9C2A311-5043-4428-89A8-CB495399B1E6

P31

Q34760010-BD25F15A-9861-456C-859E-95A463861BAF

P356

Q34760010-75CE2799-70BE-432D-A9E9-B5E6527E32B5

P433

Q34760010-94B82AA8-9AE5-4AAD-80F0-9F11891A14EA

P478

Q34760010-DC51C84A-C092-4001-BF18-FB643241864C

P50

Q34760010-D601EE30-F2C6-4312-85BF-B8DBC0C7A0F7

Q34760010-F93B05C4-E046-4930-9F5D-ABE1430EB879

P577

Q34760010-BA329896-0C3A-4E7A-9C17-0FA25C62057E

P5875

Q34760010-27943FB4-08A1-4FA1-BC66-5CA56AF0ED20

P698

Q34760010-195A9E33-97F7-450F-A6D3-FFC6CF5A8E8D

P356

14779072.6.3.343

P1433

Expert Review of Cardiovascular Therapy

P1476

Pathogenic potential of adipos ...... increased visceral adiposity.

@en

P2093

Alan Bruce Schorr

http://www.w3.org/2001/XMLSchema#string

Donald A Bergman

http://www.w3.org/2001/XMLSchema#string

Harold E Bays

http://www.w3.org/2001/XMLSchema#string

Helena W Rodbard

http://www.w3.org/2001/XMLSchema#string

J Michael González-Campoy

http://www.w3.org/2001/XMLSchema#string

Robert R Henry

http://www.w3.org/2001/XMLSchema#string

P304

343-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.6.3.343

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Abbas E Kitabchi

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5524248

http://www.w3.org/2001/XMLSchema#string

P698

18327995

http://www.w3.org/2001/XMLSchema#string